Associate Principal Scientist, Biologics Process R&d

Merck Merck · Pharma · NJ

Seeking an Associate Principal Scientist for Cell Line Development in Biologics Process R&D. Responsibilities include leading cell line development and cell banking activities, authoring regulatory submissions (IND, BLA, MAA), and supporting health authority responses. Requires strong experience in mammalian cell line development, ICH guidelines, and regulatory filing support.

What you'd actually do

  1. Lead and support cell line development and cell bank characterization activities for late-stage biologics programs.
  2. Design and execute pre-LIVCA studies, coordinate LIVCA campaigns and generate genetic stability data package to support establishment of control strategy for commercial manufacturing process. Partner with Upstream, Downstream, Analytical and Manufacturing teams.
  3. Author, review, and provide technical input for CLD-related sections of regulatory submissions, including IND, IMPD, BLA and MAA submissions, and responses to global regulatory agencies.
  4. Serve as the CLD representative on cross-functional CMC teams and partner closely with Regulatory CMC to develop scientifically robust filing strategies.
  5. Support responses to health authority questions (RTQs) related to cell line development, cell banking, clonality, genetic stability, LIVCA, and related control strategy topics.

Skills

Required

  • Ph.D. in Biology, Cell Biology, Molecular Biology, Biochemistry, Biotechnology, Chemical/Biochemical Engineering, or a related discipline with 4+ years of industry experience; or Master’s degree with 8+ years of industry experience.
  • Strong experience in mammalian cell line development, preferably using CHO-based expression systems for therapeutic proteins or monoclonal antibodies.
  • Working knowledge of ICH guidelines and regulatory expectations relevant to biotechnology-derived products, cell substrates, cell banking, and genetic stability.
  • Demonstrated experience supporting late-stage biologics programs, including pre-LIVCA studies to generate both phenotypic and genotypic stability data packages.
  • Experience authoring CLD-related regulatory submissions and supporting responses to health authority questions in collaboration with Regulatory CMC teams and cross-functional CMC development teams.
  • Strong scientific writing and communication skills, with the ability to develop clear, accurate, and well-structured technical and regulatory documents.
  • Strong understanding of cell line history, clone selection, clonality, cell substrate characterization, cell bank generation & testing, genetic stability, and LIVCA.
  • Ability to work independently, manage multiple priorities, and influence cross-functional teams effectively.

Nice to have

  • Experience supporting global regulatory submissions across major markets, including the United States, Europe, Japan and China.
  • Experience in upstream commercial process development for biologics programs.
  • Hands-on experience with cell line genetic characterization techniques including RNAseq, PCR, Southern and Northern blotting.
  • Experience preparing technical source documents, regulatory summaries, RTQs, and agency briefing materials.
  • Experience across early and late-stage biologics development, with an ability to connect CLD decisions into long-term regulatory and commercial strategy.

What the JD emphasized

  • late-stage biologics programs
  • cell line development
  • cell banking
  • regulatory strategy
  • filing authoring
  • health authority response support
  • limit of in vitro cell age (LIVCA) studies
  • ICH guidelines
  • regulatory expectations